newsfilter
← Latest News
GlobeNewswire·

Alaunos Therapeutics to Participate in the Oppenheimer 32nd Annual Healthcare Conference

HOUSTON, March 08, 2022 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. ("Alaunos" or the "Company") (NASDAQ:TCRT), a clinical-stage oncology-focused cell therapy company, today announced that the Company's Chief Executive Officer, Kevin S. Boyle Sr., a